[HTML][HTML] Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
Monoclonal antibodies with neutralizing activity against SARS-CoV-2 have demonstrated
clinical benefits in cases of mild-to-moderate SARS-CoV-2 infection, substantially reducing …
clinical benefits in cases of mild-to-moderate SARS-CoV-2 infection, substantially reducing …
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy.
R Yamin, AT Jones, HH Hoffmann, A Schäfer, KS Kao… - Nature, 2021 - europepmc.org
Monoclonal antibodies (mAbs) with neutralizing activity against SARS-CoV-2 have
demonstrated clinical benefit in cases of mild to moderate SARS-CoV-2 infection …
demonstrated clinical benefit in cases of mild to moderate SARS-CoV-2 infection …
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
R Yamin, AT Jones, HH Hoffmann, A Schäfer, KS Kao… - Nature, 2021 - ideas.repec.org
Monoclonal antibodies with neutralizing activity against SARS-CoV-2 have demonstrated
clinical benefits in cases of mild-to-moderate SARS-CoV-2 infection, substantially reducing …
clinical benefits in cases of mild-to-moderate SARS-CoV-2 infection, substantially reducing …
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
R Yamin, AT Jones, HH Hoffmann, A Schäfer… - …, 2021 - ui.adsabs.harvard.edu
Monoclonal antibodies with neutralizing activity against SARS-CoV-2 have demonstrated
clinical benefits in cases of mild-to-moderate SARS-CoV-2 infection, substantially reducing …
clinical benefits in cases of mild-to-moderate SARS-CoV-2 infection, substantially reducing …
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
R Yamin, AT Jones, HH Hoffmann, A Schäfer, KS Kao… - Nature, 2021 - cdr.lib.unc.edu
Monoclonal antibodies with neutralizing activity against SARS-CoV-2 have demonstrated
clinical benefits in cases of mild-to-moderate SARS-CoV-2 infection, substantially reducing …
clinical benefits in cases of mild-to-moderate SARS-CoV-2 infection, substantially reducing …
[PDF][PDF] Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
R Yamin, AT Jones, HH Hoffmann, A Schäfer, KS Kao… - scholar.archive.org
Monoclonal antibodies with neutralizing activity against SARS-CoV-2 have demonstrated
clinical benefits in cases of mild-to-moderate SARS-CoV-2 infection, substantially reducing …
clinical benefits in cases of mild-to-moderate SARS-CoV-2 infection, substantially reducing …
[HTML][HTML] Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
R Yamin, AT Jones, HH Hoffmann, A Schäfer, KS Kao… - Nature, 2021 - ncbi.nlm.nih.gov
Monoclonal antibodies (mAbs) with neutralizing activity against SARS-CoV-2 have
demonstrated clinical benefit in cases of mild to moderate SARS-CoV-2 infection …
demonstrated clinical benefit in cases of mild to moderate SARS-CoV-2 infection …
[引用][C] Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
R Yamin, AT Jones, HH Hoffmann, A Schäfer, KS Kao… - Nature, 2021 - cir.nii.ac.jp
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
R Yamin, AT Jones, HH Hoffmann, A Schäfer… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Monoclonal antibodies with neutralizing activity against SARS-CoV-2 have demonstrated
clinical benefits in cases of mild-to-moderate SARS-CoV-2 infection, substantially reducing …
clinical benefits in cases of mild-to-moderate SARS-CoV-2 infection, substantially reducing …
Fc-engineered antibody therapeutics with improved anti-SARS-CoV-2 efficacy
R Yamin, AT Jones, HH Hoffmann, A Schäfer… - Nature, 2021 - econpapers.repec.org
Monoclonal antibodies with neutralizing activity against SARS-CoV-2 have demonstrated
clinical benefits in cases of mild-to-moderate SARS-CoV-2 infection, substantially reducing …
clinical benefits in cases of mild-to-moderate SARS-CoV-2 infection, substantially reducing …